It has previously been shown that there is a correlation of VEGF expression with IL-6 and its receptors in tumor cells, which is associated with poor survival of individuals with HER2-invasive ductal carcinoma [27]. This evidence concerns the gene ERBB2 and invasive ductal breast carcinoma.